3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Neoplasms
2
Multiple Myeloma
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Tooth, Impacted
1
Stomach Neoplasms
1
Sepsis
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Postoperative Nausea and Vomiting
1
Polycystic Ovary Syndrome
1
Peripheral Nervous System Diseases
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Pain
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Menstruation Disturbances
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma
1
Lymphedema
1
Lung Neoplasms
1
Insulin Resistance
1
Ileus
1
Hyperandrogenism
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Metformin
2
salicylsalicylic acid
1
maltodextrin
1
licogliflozin
1
Sugars
1
Sodium Salicylate
1
Inulin
1
Inositol
1
Flutamide
1
Clomiphene
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Hyperandrogenism
×
Acupuncture Therapy
×
Clear all
NCT02647827
2024-10-09
PIAII
Karolinska Institutet
Phase 2
Recruiting
303 enrolled